U.S. pharma giant copyright scrapped two experimental weight loss capsules final yr—a as soon as-each day tablet, lotiglipron, due to elevated liver enzymes in addition to a 2 times-everyday pill, danuglipron, because of robust Unwanted side effects—but CEO Albert Bourla has claimed the company is set to “Engage in and earn” during the bein